Skip to Primary Navigation

EU adopts pharma reform to boost access, innovation, and supply

A photo of a detail of the flag of the European Union (Blue background with two gold stars) on the left side on a blurred background.
Photo: Thierry Monasse/Getty Images

New pharmaceutical rules aim to expand medicine access, strengthen supply security, and reshape incentives for EU innovation.

With the goal of improving access to medicines, supporting innovation, and strengthening supply resilience across the bloc, the Council of the European Union has adopted a raft of pharmaceutical legislation.

Adopted on September 28, the reforms composing the so-called “pharma package” are intended to improve patient access to safe, effective,

“With

Get full access, free for a month

Start your 28-day free trial to continue reading and accessall content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience